Cargando…

Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis

BACKGROUND: The disruption of endothelial homeostasis is a major determinant in the pathogenesis of systemic sclerosis (SSc) and is reflected by soluble and cellular markers of activation, injury and repair. We aimed to provide a combined assessment of endothelial markers to delineate specific profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Benyamine, Audrey, Magalon, Jérémy, Cointe, Sylvie, Lacroix, Romaric, Arnaud, Laurent, Bardin, Nathalie, Rossi, Pascal, Francès, Yves, Bernard-Guervilly, Fanny, Kaplanski, Gilles, Harlé, Jean-Robert, Weiller, Pierre-Jean, Berbis, Philippe, Braunstein, David, Jouve, Elisabeth, Lesavre, Nathalie, Couranjou, Françoise, Dignat-George, Françoise, Sabatier, Florence, Paul, Pascale, Granel, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359964/
https://www.ncbi.nlm.nih.gov/pubmed/28320472
http://dx.doi.org/10.1186/s13075-017-1271-7
_version_ 1782516496537223168
author Benyamine, Audrey
Magalon, Jérémy
Cointe, Sylvie
Lacroix, Romaric
Arnaud, Laurent
Bardin, Nathalie
Rossi, Pascal
Francès, Yves
Bernard-Guervilly, Fanny
Kaplanski, Gilles
Harlé, Jean-Robert
Weiller, Pierre-Jean
Berbis, Philippe
Braunstein, David
Jouve, Elisabeth
Lesavre, Nathalie
Couranjou, Françoise
Dignat-George, Françoise
Sabatier, Florence
Paul, Pascale
Granel, Brigitte
author_facet Benyamine, Audrey
Magalon, Jérémy
Cointe, Sylvie
Lacroix, Romaric
Arnaud, Laurent
Bardin, Nathalie
Rossi, Pascal
Francès, Yves
Bernard-Guervilly, Fanny
Kaplanski, Gilles
Harlé, Jean-Robert
Weiller, Pierre-Jean
Berbis, Philippe
Braunstein, David
Jouve, Elisabeth
Lesavre, Nathalie
Couranjou, Françoise
Dignat-George, Françoise
Sabatier, Florence
Paul, Pascale
Granel, Brigitte
author_sort Benyamine, Audrey
collection PubMed
description BACKGROUND: The disruption of endothelial homeostasis is a major determinant in the pathogenesis of systemic sclerosis (SSc) and is reflected by soluble and cellular markers of activation, injury and repair. We aimed to provide a combined assessment of endothelial markers to delineate specific profiles associated with SSc disease and its severity. METHODS: We conducted an observational, single-centre study comprising 45 patients with SSc and 41 healthy control subjects. Flow cytometry was used to quantify circulating endothelial microparticles (EMPs) and CD34(+) progenitor cell subsets. Colony-forming unit-endothelial cells (CFU-ECs) were counted by culture assay. Circulating endothelial cells were enumerated using anti-CD146-based immunomagnetic separation. Blood levels of endothelin-1, vascular endothelial growth factor (VEGF) and soluble fractalkine (s-Fractalkine) were evaluated by enzyme-linked immunosorbent assay. Disease-associated markers were identified using univariate, correlation and multivariate analyses. RESULTS: Enhanced numbers of EMPs, CFU-ECs and non-haematopoietic CD34(+)CD45(−) endothelial progenitor cells (EPCs) were observed in patients with SSc. Patients with SSc also displayed higher serum levels of VEGF, endothelin-1 and s-Fractalkine. s-Fractalkine levels positively correlated with CD34(+)CD45(−) EPC numbers. EMPs, s-Fractalkine and endothelin-1 were independent factors associated with SSc. Patients with high CD34(+)CD45(−) EPC numbers had lower forced vital capacity values. Elevated s-Fractalkine levels were associated with disease severity, a higher frequency of pulmonary fibrosis and altered carbon monoxide diffusion. CONCLUSIONS: This study identifies the mobilisation of CD34(+)CD45(−) EPCs and high levels of s-Fractalkine as specific features of SSc-associated vascular activation and disease severity. This signature may provide novel insights linking endothelial inflammation and defective repair processes in the pathogenesis of SSc. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1271-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5359964
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53599642017-03-22 Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis Benyamine, Audrey Magalon, Jérémy Cointe, Sylvie Lacroix, Romaric Arnaud, Laurent Bardin, Nathalie Rossi, Pascal Francès, Yves Bernard-Guervilly, Fanny Kaplanski, Gilles Harlé, Jean-Robert Weiller, Pierre-Jean Berbis, Philippe Braunstein, David Jouve, Elisabeth Lesavre, Nathalie Couranjou, Françoise Dignat-George, Françoise Sabatier, Florence Paul, Pascale Granel, Brigitte Arthritis Res Ther Research Article BACKGROUND: The disruption of endothelial homeostasis is a major determinant in the pathogenesis of systemic sclerosis (SSc) and is reflected by soluble and cellular markers of activation, injury and repair. We aimed to provide a combined assessment of endothelial markers to delineate specific profiles associated with SSc disease and its severity. METHODS: We conducted an observational, single-centre study comprising 45 patients with SSc and 41 healthy control subjects. Flow cytometry was used to quantify circulating endothelial microparticles (EMPs) and CD34(+) progenitor cell subsets. Colony-forming unit-endothelial cells (CFU-ECs) were counted by culture assay. Circulating endothelial cells were enumerated using anti-CD146-based immunomagnetic separation. Blood levels of endothelin-1, vascular endothelial growth factor (VEGF) and soluble fractalkine (s-Fractalkine) were evaluated by enzyme-linked immunosorbent assay. Disease-associated markers were identified using univariate, correlation and multivariate analyses. RESULTS: Enhanced numbers of EMPs, CFU-ECs and non-haematopoietic CD34(+)CD45(−) endothelial progenitor cells (EPCs) were observed in patients with SSc. Patients with SSc also displayed higher serum levels of VEGF, endothelin-1 and s-Fractalkine. s-Fractalkine levels positively correlated with CD34(+)CD45(−) EPC numbers. EMPs, s-Fractalkine and endothelin-1 were independent factors associated with SSc. Patients with high CD34(+)CD45(−) EPC numbers had lower forced vital capacity values. Elevated s-Fractalkine levels were associated with disease severity, a higher frequency of pulmonary fibrosis and altered carbon monoxide diffusion. CONCLUSIONS: This study identifies the mobilisation of CD34(+)CD45(−) EPCs and high levels of s-Fractalkine as specific features of SSc-associated vascular activation and disease severity. This signature may provide novel insights linking endothelial inflammation and defective repair processes in the pathogenesis of SSc. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1271-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-20 2017 /pmc/articles/PMC5359964/ /pubmed/28320472 http://dx.doi.org/10.1186/s13075-017-1271-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Benyamine, Audrey
Magalon, Jérémy
Cointe, Sylvie
Lacroix, Romaric
Arnaud, Laurent
Bardin, Nathalie
Rossi, Pascal
Francès, Yves
Bernard-Guervilly, Fanny
Kaplanski, Gilles
Harlé, Jean-Robert
Weiller, Pierre-Jean
Berbis, Philippe
Braunstein, David
Jouve, Elisabeth
Lesavre, Nathalie
Couranjou, Françoise
Dignat-George, Françoise
Sabatier, Florence
Paul, Pascale
Granel, Brigitte
Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis
title Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis
title_full Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis
title_fullStr Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis
title_full_unstemmed Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis
title_short Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis
title_sort increased serum levels of fractalkine and mobilisation of cd34(+)cd45(−) endothelial progenitor cells in systemic sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359964/
https://www.ncbi.nlm.nih.gov/pubmed/28320472
http://dx.doi.org/10.1186/s13075-017-1271-7
work_keys_str_mv AT benyamineaudrey increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT magalonjeremy increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT cointesylvie increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT lacroixromaric increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT arnaudlaurent increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT bardinnathalie increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT rossipascal increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT francesyves increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT bernardguervillyfanny increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT kaplanskigilles increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT harlejeanrobert increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT weillerpierrejean increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT berbisphilippe increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT braunsteindavid increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT jouveelisabeth increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT lesavrenathalie increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT couranjoufrancoise increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT dignatgeorgefrancoise increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT sabatierflorence increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT paulpascale increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis
AT granelbrigitte increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis